ArticleMultiple sclerosis and related disorders2022

Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.

Tobias Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.